Literature DB >> 30302045

Role of Peripheral Inflammation in Hepatic Encephalopathy.

Hassan Azhari1, Mark G Swain1.   

Abstract

A growing body of evidence now highlights a key role for systemic inflammation in altering behavior and mood in patients with liver disease. How inflammation occurring in the periphery in the context of liver disease, communicates with the brain to mediate changes in neurotransmission and thereby behavior is incompletely understood. Traditional routes of communication between the periphery and the brain involve neural (i.e. vagal afferent nerves) and humoral (blood-borne) pathways, with increased circulating levels of endotoxin and cytokines (especially Tumor Necrosis Factor α, TNFα) that occur during systemic inflammatory responses, as being primarily implicated in mediating signaling via these pathways. However, in recent years communication via peripheral immune-cell-to-brain and the gut-microbiota-to-brain routes have received increasing attention in the context of liver disease for their ability to modulate brain function, and generate a spectrum of symptoms ranging from fatigue and altered mood to overt Hepatic Encephalopathy (HE). In this review, we discuss periphery-to-brain communication pathways and their potential role in mediating systemic inflammation-associated alterations in behavior, that are in turn ultimately part of a spectrum of brain changes linked to the development of clinically apparent HE.

Entities:  

Keywords:  CECs, Cerebral Endothelial Cells; HE, Hepatic Encephalopathy; IL, Interleukin; LPS, Lipopolysaccharide; MPA, Monocyte Platelet Aggregate; PSGL-1, Anti-P-Selectin Glycoprotein 1; QoL, Quality of Life; SIBO, Small Intestinal Bacterial Overgrowth; TNF-α, Tumor Necrosis Factor-Alpha; cytokines; dysbiosis; gut microbiome; microglia; systemic inflammation

Year:  2018        PMID: 30302045      PMCID: PMC6175767          DOI: 10.1016/j.jceh.2018.06.008

Source DB:  PubMed          Journal:  J Clin Exp Hepatol        ISSN: 0973-6883


  33 in total

Review 1.  Inflammation: A novel target of current therapies for hepatic encephalopathy in liver cirrhosis.

Authors:  Ming Luo; Jian-Yang Guo; Wu-Kui Cao
Journal:  World J Gastroenterol       Date:  2015-11-07       Impact factor: 5.742

Review 2.  Immune system to brain signaling: neuropsychopharmacological implications.

Authors:  Lucile Capuron; Andrew H Miller
Journal:  Pharmacol Ther       Date:  2011-02-17       Impact factor: 12.310

3.  Immune dysfunction in cirrhosis: Distinct cytokines phenotypes according to cirrhosis severity.

Authors:  Melisa Dirchwolf; Ariel Podhorzer; Monica Marino; Carolina Shulman; Mariano Cartier; Moira Zunino; Silvia Paz; Alberto Muñoz; Andrea Bocassi; Juan Gimenez; Lucía Di Pietro; Gustavo Romero; Hugo Fainboim; Leonardo Fainboim
Journal:  Cytokine       Date:  2015-10-23       Impact factor: 3.861

4.  Interactions Between Platelets and Inflammatory Monocytes Affect Sickness Behavior in Mice With Liver Inflammation.

Authors:  Charlotte D'Mello; Wagdi Almishri; Hongqun Liu; Mark Gordon Swain
Journal:  Gastroenterology       Date:  2017-08-09       Impact factor: 22.682

5.  Probiotic VSL#3 reduces liver disease severity and hospitalization in patients with cirrhosis: a randomized, controlled trial.

Authors:  Radha K Dhiman; Baldev Rana; Swastik Agrawal; Ashish Garg; Madhu Chopra; Kiran K Thumburu; Amit Khattri; Samir Malhotra; Ajay Duseja; Yogesh K Chawla
Journal:  Gastroenterology       Date:  2014-08-27       Impact factor: 22.682

6.  Consumption of fermented milk product with probiotic modulates brain activity.

Authors:  Kirsten Tillisch; Jennifer Labus; Lisa Kilpatrick; Zhiguo Jiang; Jean Stains; Bahar Ebrat; Denis Guyonnet; Sophie Legrain-Raspaud; Beatrice Trotin; Bruce Naliboff; Emeran A Mayer
Journal:  Gastroenterology       Date:  2013-03-06       Impact factor: 22.682

Review 7.  Neuroinflammation: the devil is in the details.

Authors:  Damon J DiSabato; Ning Quan; Jonathan P Godbout
Journal:  J Neurochem       Date:  2016-05-04       Impact factor: 5.372

8.  Persistent fatigue in liver transplant recipients: a two-year follow-up study.

Authors:  Berbke T J van Ginneken; Rita J G van den Berg-Emons; Anna van der Windt; Huug W Tilanus; Herold J Metselaar; Henk J Stam; Geert Kazemier
Journal:  Clin Transplant       Date:  2009-09-11       Impact factor: 2.863

9.  Altered profile of human gut microbiome is associated with cirrhosis and its complications.

Authors:  Jasmohan S Bajaj; Douglas M Heuman; Phillip B Hylemon; Arun J Sanyal; Melanie B White; Pamela Monteith; Nicole A Noble; Ariel B Unser; Kalyani Daita; Andmorgan R Fisher; Masoumeh Sikaroodi; Patrick M Gillevet
Journal:  J Hepatol       Date:  2013-12-25       Impact factor: 25.083

10.  Modulation of the metabiome by rifaximin in patients with cirrhosis and minimal hepatic encephalopathy.

Authors:  Jasmohan S Bajaj; Douglas M Heuman; Arun J Sanyal; Phillip B Hylemon; Richard K Sterling; R Todd Stravitz; Michael Fuchs; Jason M Ridlon; Kalyani Daita; Pamela Monteith; Nicole A Noble; Melanie B White; Andmorgan Fisher; Masoumeh Sikaroodi; Huzefa Rangwala; Patrick M Gillevet
Journal:  PLoS One       Date:  2013-04-02       Impact factor: 3.240

View more
  9 in total

1.  Therapeutic potential of probiotics - Lactobacillus plantarum UBLP40 and Bacillus clausii UBBC07 on thioacetamide-induced acute hepatic encephalopathy in rats.

Authors:  Lalita Shahgond; Chirag Patel; Khushboo Thakur; Dipta Sarkar; Sanjeev Acharya; Priyanshi Patel
Journal:  Metab Brain Dis       Date:  2021-11-03       Impact factor: 3.584

Review 2.  Hepatic encephalopathy.

Authors:  Dieter Häussinger; Radha K Dhiman; Vicente Felipo; Boris Görg; Rajiv Jalan; Gerald Kircheis; Manuela Merli; Sara Montagnese; Manuel Romero-Gomez; Alfons Schnitzler; Simon D Taylor-Robinson; Hendrik Vilstrup
Journal:  Nat Rev Dis Primers       Date:  2022-06-23       Impact factor: 65.038

Review 3.  Proceedings from the 2018 Canadian Association for the Study of the Liver Single Topic Conference-Decompensated cirrhosis: from clinic to transplant.

Authors:  Victor Dong; Maxime Gosselin; Nishita Jagarlamudi; Beverley Kok; Mark G Swain; Jasmohan S Bajaj; Juan G Abraldes; Vladimir Marquez; R Todd Stravitz; Aldo J Montano-Loza; Manuela Merli; Phil Wong; Amanda Brisebois; Puneeta Tandon; Julia Wendon; Scott L Nyberg; François M Carrier; Michael R Lucey; Florence Wong; Jordan J Feld; Constantine J Karvellas; Christopher F Rose; Julien Bissonnette
Journal:  Can Liver J       Date:  2019-12-10

4.  The critical role of hippocampal dopamine in the pathogenesis of hepatic encephalopathy.

Authors:  B Chen; Y Yang; S Li; X Zhu; Y Qi; F Hong
Journal:  Physiol Res       Date:  2021-01-14       Impact factor: 1.881

Review 5.  Dietary approach and gut microbiota modulation for chronic hepatic encephalopathy in cirrhosis.

Authors:  Daniela Campion; Ilaria Giovo; Paola Ponzo; Giorgio M Saracco; Federico Balzola; Carlo Alessandria
Journal:  World J Hepatol       Date:  2019-06-27

Review 6.  The Role of Intestinal Bacteria and Gut-Brain Axis in Hepatic Encephalopathy.

Authors:  Zefeng Chen; Jingsheng Ruan; Dinghua Li; Min Wang; Zhiwei Han; Wenxia Qiu; Guobin Wu
Journal:  Front Cell Infect Microbiol       Date:  2021-01-21       Impact factor: 5.293

Review 7.  The Association between Hepatic Encephalopathy and Diabetic Encephalopathy: The Brain-Liver Axis.

Authors:  So Yeong Cheon; Juhyun Song
Journal:  Int J Mol Sci       Date:  2021-01-05       Impact factor: 5.923

Review 8.  Recent advances in understanding and managing hepatic encephalopathy in chronic liver disease.

Authors:  Annarein J C Kerbert; Rajiv Jalan
Journal:  F1000Res       Date:  2020-04-29

Review 9.  Novel Insights Into Pathogenesis and Therapeutic Strategies of Hepatic Encephalopathy, From the Gut Microbiota Perspective.

Authors:  Jiachen Liu; Yantao Xu; Bimei Jiang
Journal:  Front Cell Infect Microbiol       Date:  2021-02-22       Impact factor: 5.293

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.